TAF2（TATA-box binding protein associated factor 2）是转录因子IID（TFIID）复合体的核心组成部分，属于TAF基因家族。该家族成员（如TAF1-TAF15）的共同特点是参与RNA聚合酶II介导的转录起始，通过与TBP（TATA-box结合蛋白）结合形成TFIID复合体，识别核心启动子区域的TATA盒或其他启动子元件，调控基因表达。TAF2在转录起始中发挥关键作用，其N端结构域直接结合TBP，而C端则与其他TAF蛋白相互作用，稳定TFIID复合体的组装。TAF2的表达产物（蛋白质）在细胞核内发挥作用，主要影响细胞周期调控、分化和发育相关基因的转录激活。若TAF2发生功能丧失性突变（如错义突变或截短突变），可能导致TFIID复合体组装异常，破坏全局转录调控，引发胚胎发育缺陷或细胞增殖紊乱。研究发现TAF2突变与某些癌症（如结直肠癌）和神经发育障碍相关。当TAF2过表达时，可能异常激活下游促增殖基因（如细胞周期蛋白），促进肿瘤发生；而表达降低则会导致转录抑制，影响细胞存活。TAF家族蛋白的共性包括：含有保守的组蛋白折叠结构域（histone fold domain），介导蛋白互作；参与染色质重塑和表观遗传调控；部分成员（如TAF4/TAF12）还具有类泛素化修饰功能。需要注意的是，"TAF"在不同语境中可能指代不同家族成员（如TAF1是激酶，TAF15涉及RNA代谢），但均与转录调控网络密切相关。

由RNA聚合酶II转录起始需要70多个多肽的活动。它协调这些活动的蛋白质是转录因子的IID（TFIID），其结合到核心启动子正确定位聚合酶，作为支架的转录复合物的其余部分的组件，并作为调节信号的信道。 TFIID是由TATA结合蛋白（TBP）和一组被称为TBP相关因子或TAFS进化保守的蛋白质的。 TAFS可能参与基础转录，作为共激活因子，功能的启动子识别或修改一般转录因子（基转移酶），以方便复杂的组装和转录起始。这个基因编码被稳定地与TFIID复杂关联TFIID的较大亚单位中的一个。它有助于在转录起始位点，相互作用，以帮助确定要活化转录复合响应的和下游的相互作用。 [由RefSeq的，2008年7月提供]

TAF2, also known as TATA-box binding protein associated factor 2, is a critical subunit of the transcription factor IID (TFIID) complex, a multi-protein assembly essential for the initiation of eukaryotic transcription by RNA polymerase II. As a member of the TAF gene family, TAF2 contributes to the recognition of core promoter elements, particularly the TATA box, by serving as a structural bridge within the TFIID complex; its N-terminal domain directly binds to the TATA-box binding protein (TBP), while its C-terminal region interacts with other TAF subunits to stabilize the overall architecture of the complex. This precise assembly enables the recruitment of RNA polymerase II to specific genomic loci, thereby regulating the transcription of genes involved in cell cycle control, differentiation, and developmental processes. TAF2 is predominantly localized in the nucleus, where it exerts its function through conserved histone fold domains that mediate protein-protein interactions, facilitating chromatin remodeling and epigenetic regulation. Disruption of TAF2 function, such as through loss-of-function mutations including missense or truncation variants, can impair TFIID assembly and global transcriptional regulation, leading to severe phenotypic consequences such as embryonic developmental defects and aberrant cell proliferation. Conversely, dysregulated TAF2 expression has significant implications for disease pathology; overexpression may aberrantly activate downstream pro-proliferative genes, including cyclins, thereby promoting tumorigenesis, while reduced expression can suppress essential transcriptional programs, compromising cell survival. Recent studies have linked TAF2 mutations to various cancers, notably colorectal cancer, as well as neurodevelopmental disorders, underscoring its vital role in maintaining genomic stability and proper cellular homeostasis within the broader transcriptional regulatory network.

Loading comments...